CMS to Cover NGS Companion Diagnostics.
The Centers for Medicare & Medicaid Services recently announced that next-generation sequencing-based companion diagnostics will be covered for beneficiaries with advanced cancer. This announcement takes coverage decisions out of the hands of local contractors, providing more uniform access to such tests.